xCures Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $46M

  • Investors
  • 19

xCures General Information

Description

Developer of a clinical data management platform designed to transform fragmented medical records into structured, decision-ready information. The company's technology utilizes a clinical clarity engine to retrieve, normalize, and segment medical documents into longitudinal patient histories and source-linked checklists, enabling healthcare organizations to access verifiable clinical data for faster chart review and informed decision-making.

Contact Information

Website
www.xcures.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1901 Harrison Street
  • Suite 1100
  • Oakland, CA 94612
  • United States
+1 (707)
Primary Industry
Medical Records Systems
Other Industries
Enterprise Systems (Healthcare)
Decision/Risk Analysis
Corporate Office
  • 1901 Harrison Street
  • Suite 1100
  • Oakland, CA 94612
  • United States
+1 (707)

xCures Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

xCures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 24-Jun-2026 $46M Completed Generating Revenue
4. Later Stage VC 01-Dec-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 20-Dec-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 23-Jun-2021 $12.7M $17.9M Completed Generating Revenue
1. Seed Round 28-Feb-2020 $5.2M $5.2M Completed Generating Revenue
To view xCures’s complete valuation and funding history, request access »

xCures Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A
Seed-2 3,968,767 $0.000100 8% $0.5 $0.5 1x $0.5 4.99%
Seed-1 6,134,306 $0.000100 8% $0.55 $0.55 1x $0.55 7.72%
To view xCures’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

xCures Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical data management platform designed to transform fragmented medical records into structured, decis
Medical Records Systems
Oakland, CA
50 As of 2026

San Diego, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

xCures Competitors (26)

One of xCures’s 26 competitors is ForeSee Medical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ForeSee Medical Venture Capital-Backed San Diego, CA
Innovaccer Venture Capital-Backed San Francisco, CA
LogicStream Health Private Equity-Backed Minneapolis, MN
HealthPlix Venture Capital-Backed Bengaluru, India
MediSpend Private Equity-Backed Portsmouth, NH
You’re viewing 5 of 26 competitors. Get the full list »

xCures Patents

xCures Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4222605-A1 Automated individualized recommendations for medical treatment Pending 29-Sep-2020
EP-4222605-A4 Automated individualized recommendations for medical treatment Pending 29-Sep-2020
US-20230343468-A1 Automated individualized recommendations for medical treatment Pending 29-Sep-2020
WO-2022072346-A1 Automated individualized recommendations for medical treatment Inactive 29-Sep-2020
EP-4214614-A1 Dynamic in-transit structuring of unstructured medical documents Pending 18-Sep-2020 G06F40/151
To view xCures’s complete patent history, request access »

xCures Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

xCures Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charles & Potomac Capital Family Office Minority
GKCC Venture Capital Minority
HBS Alumni Angels of Greater New York Angel Group Minority
iGrow Venture Capital Venture Capital Minority
Innovius Capital Management Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

xCures FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process